These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26691655)

  • 1. Closed-loop glycaemic control using an implantable artificial pancreas in diabetic domestic pig (Sus scrofa domesticus).
    Taylor MJ; Gregory R; Tomlins P; Jacob D; Hubble J; Sahota TS
    Int J Pharm; 2016 Mar; 500(1-2):371-8. PubMed ID: 26691655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas.
    Renard E; Place J; Cantwell M; Chevassus H; Palerm CC
    Diabetes Care; 2010 Jan; 33(1):121-7. PubMed ID: 19846796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypoglycemic effect of chitosan-microcapsulated insulin on the blood glucose level of streptozotocin-diabetic Wistar rats].
    Huang H; Tian H; Li X; Zhao G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Sep; 18(3):425-7, 460. PubMed ID: 11605507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion.
    Zisser H; Dassau E; Lee JJ; Harvey RA; Bevier W; Doyle FJ
    J Diabetes Sci Technol; 2015 May; 9(3):564-72. PubMed ID: 25901023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A feasibility study of bihormonal closed-loop blood glucose control using dual subcutaneous infusion of insulin and glucagon in ambulatory diabetic swine.
    El-Khatib FH; Jiang J; Damiano ER
    J Diabetes Sci Technol; 2009 Jul; 3(4):789-803. PubMed ID: 20144330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who needs an artificial pancreas? (？).
    Winikoff J; Drexler A
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-breakfast closed-loop glucose control is improved when accompanied with carbohydrate-matching bolus compared to weight-dependent bolus.
    Haidar A; Farid D; St-Yves A; Messier V; Chen V; Xing D; Brazeau AS; Duval C; Boulet B; Legault L; Rabasa-Lhoret R
    Diabetes Metab; 2014 Jun; 40(3):211-4. PubMed ID: 24656963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of blood glucose and insulin infusion rate in real-time in diabetic rats using an artificial pancreas system.
    Kirilmaz OB; Salegaonkar AR; Shiau J; Uzun G; Ko HS; Lee HF; Park S; Kwon G
    PLoS One; 2021; 16(7):e0254718. PubMed ID: 34270619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
    Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L;
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased responses of glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment.
    Wan CK; Giacca A; Matsuhisa M; El-Bahrani B; Lam L; Rodgers C; Shi ZQ
    Metabolism; 2000 Aug; 49(8):984-9. PubMed ID: 10954014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated overnight closed-loop glucose control in young children with type 1 diabetes.
    Elleri D; Allen JM; Nodale M; Wilinska ME; Mangat JS; Larsen AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Technol Ther; 2011 Apr; 13(4):419-24. PubMed ID: 21355719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
    Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes.
    Haidar A; Rabasa-Lhoret R; Legault L; Lovblom LE; Rakheja R; Messier V; D'Aoust É; Falappa CM; Justice T; Orszag A; Tschirhart H; Dallaire M; Ladouceur M; Perkins BA
    J Clin Endocrinol Metab; 2016 Jan; 101(1):214-23. PubMed ID: 26523526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent hypoglycaemic activity of the aqueous extract of Chamaemelum nobile in normal and streptozotocin-induced diabetic rats.
    Eddouks M; Lemhadri A; Zeggwagh NA; Michel JB
    Diabetes Res Clin Pract; 2005 Mar; 67(3):189-95. PubMed ID: 15713350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats.
    Qinna NA; Badwan AA
    Drug Des Devel Ther; 2015; 9():2515-25. PubMed ID: 26005328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.